Our
Clients
: Aug, 2020
: 100
:
Global E-Prescribing (e-Rx) Market
Market Overview:
The global E-Prescribing (e-Rx) market was valued at USD 3.06 billion in 2022 and expected to grow at a CAGR of 20.7% during the forecast period. E-Prescribing (e-Rx) is the electronic transmission of a prescription from a healthcare provider to a pharmacy. E-prescribing systems have replaced the traditional paper-based prescription system, making the prescription process more efficient, accurate, and secure. The process of e-prescribing involves the use of computerized prescribing software that allows healthcare providers to transmit electronic prescriptions directly to a patients pharmacy of choice.
E-prescribing systems have a range of benefits over traditional paper-based systems. These benefits include:
Improved patient safety: E-prescribing reduces the risk of errors associated with manual transcription of prescriptions. The system provides real-time access to patient medication history and potential drug interactions, which helps to prevent adverse drug events.
Increased efficiency: E-prescribing eliminates the need for paper-based prescriptions, which can be time-consuming and error-prone. The system allows healthcare providers to quickly and accurately prescribe medications, which can save time and reduce costs associated with errors.
Cost-effective: E-prescribing systems can reduce the cost of prescription processing by reducing the need for manual data entry and paper-based systems.
Improved patient adherence: E-prescribing systems can improve patient adherence to medication regimens by providing reminders and alerts to patients when it is time to refill their prescriptions.
Enhanced security: E-prescribing systems provide a secure method for transmitting prescriptions, which helps to reduce the risk of fraud and unauthorized access to patient information.
E-prescribing systems are also integrated with electronic health record (EHR) systems, which allows healthcare providers to access a patient's medical history and other relevant information. E-prescribing is becoming increasingly common in the healthcare industry and is expected to continue to grow as more providers and pharmacies adopt the system.
Chart
Covid-19 Impact:
The COVID-19 pandemic has had a significant impact on the healthcare industry, including the e-prescribing (e-Rx) system. The pandemic has accelerated the adoption of e-prescribing systems due to the need for social distancing measures and the importance of reducing the risk of virus transmission. Here are some of the ways in which COVID-19 has impacted the e-prescribing system:
Increased demand: The COVID-19 pandemic has increased the demand for e-prescribing systems as healthcare providers seek to reduce the risk of transmission by minimizing in-person visits to pharmacies. This has resulted in an increase in the number of e-prescriptions being transmitted.
Remote prescribing: The pandemic has also led to an increase in telemedicine and remote healthcare services, which has made e-prescribing even more critical. Healthcare providers can prescribe medications remotely, and patients can receive their prescriptions from any pharmacy of their choice.
Expansion of e-prescribing: The pandemic has led to the expansion of e-prescribing to new regions and healthcare settings. For example, many states in the US have relaxed regulations around e-prescribing to allow for more widespread adoption during the pandemic.
Improved patient safety: E-prescribing has helped to improve patient safety during the pandemic by reducing the risk of transmission associated with paper-based prescriptions. It also provides real-time access to patient medication history and potential drug interactions, which helps to prevent adverse drug events.
Technology innovation: The pandemic has led to the development of new technology solutions for e-prescribing. For example, some companies have developed touchless prescription systems that eliminate the need for patients to physically sign for their prescriptions.
In summary, the COVID-19 pandemic has accelerated the adoption of e-prescribing systems in the healthcare industry. The system has helped to reduce the risk of transmission and improve patient safety during the pandemic, while also providing greater convenience and flexibility for patients and healthcare providers.
Market Dynamics:
Drivers:
Improving patient safety: E-prescribing helps to reduce the risk of medication errors, such as misreading a handwritten prescription or prescribing an incorrect dosage. The system provides real-time access to patient medication history and potential drug interactions, which helps to prevent adverse drug events.
Increasing efficiency: E-prescribing eliminates the need for paper-based prescriptions, which can be time-consuming and error-prone. The system allows healthcare providers to quickly and accurately prescribe medications, which can save time and reduce costs associated with errors.
Enhancing prescription accuracy: E-prescribing systems ensure that prescriptions are accurate and legible, reducing the risk of errors due to illegible handwriting or transcription mistakes.
Streamlining the prescription process: E-prescribing eliminates the need for patients to carry paper prescriptions, which can be lost or misplaced. Patients can receive their prescriptions electronically and can choose to have them sent directly to a pharmacy of their choice.
Improving medication adherence: E-prescribing systems can improve patient adherence to medication regimens by providing reminders and alerts to patients when it is time to refill their prescriptions.
Reducing healthcare costs: E-prescribing can reduce healthcare costs by reducing the need for manual data entry and paper-based systems. It can also help to reduce the costs associated with medication errors and adverse drug events.
Enabling telemedicine: E-prescribing systems can enable telemedicine and remote healthcare services, allowing healthcare providers to prescribe medications remotely, and patients to receive their prescriptions from any pharmacy of their choice.
Overall, the driving factors for e-prescribing adoption are centered around improving patient safety, increasing efficiency, and reducing healthcare costs. The system provides a secure and accurate method for transmitting prescriptions, which helps to improve patient outcomes and streamline the prescription process for healthcare providers and patients alike.
Restraints:
Cost of implementation: Implementing an e-prescribing system can be costly for healthcare providers, particularly for small practices that may not have the resources to invest in new technology.
Integration with existing systems: Integrating an e-prescribing system with existing electronic health record (EHR) systems can be challenging, and may require significant technical expertise.
Lack of standardization: There is currently no national standard for e-prescribing, which can make it difficult for healthcare providers to adopt the technology. Different systems may use different formats or protocols, which can lead to interoperability issues.
Resistance to change: Some healthcare providers may be resistant to change and prefer traditional paper-based prescription methods, which can slow down the adoption of e-prescribing.
Regulatory barriers: In some regions, regulations may prohibit or limit the use of e-prescribing. This can be a significant restraining factor for healthcare providers who may be hesitant to adopt new technology that is not fully supported by regulatory bodies.
Security concerns: E-prescribing systems must be secure and protect patient information from cyber threats. Concerns about the security of e-prescribing systems can be a restraining factor for healthcare providers who may be hesitant to adopt new technology that is not fully secure.
Overall, while e-prescribing has many benefits, there are several factors that can slow down its adoption, including cost, integration challenges, lack of standardization, resistance to change, regulatory barriers, and security concerns. Healthcare providers and regulatory bodies need to work together to address these challenges and create a more streamlined and secure e-prescribing system.
Segment Analysis:
Solutions: E-prescribing solutions are software systems that enable healthcare providers to electronically create and transmit prescriptions to pharmacies. These solutions can be standalone systems or integrated with electronic health record (EHR) systems. E-prescribing solutions typically include features such as patient information management, drug reference databases, and drug interaction checking. They are designed to improve patient safety, reduce medication errors, and streamline prescription management for healthcare providers.
Services: E-prescribing services are professional services that support the implementation, management, and optimization of e-prescribing solutions. These services may include consulting, training, technical support, and maintenance. E-prescribing services are designed to help healthcare providers successfully adopt and utilize e-prescribing solutions, ensuring that they are effective, efficient, and meet the unique needs of each provider.
Overall, both e-prescribing solutions and services are essential for the successful implementation and adoption of e-prescribing technology in healthcare. Solutions provide the technological infrastructure for e-prescribing, while services provide the support and expertise needed to ensure that the technology is effectively utilized and optimized. As the demand for e-prescribing continues to grow, both solutions and services will play a critical role in improving patient safety and efficiency in healthcare.
Segment
Regional Analysis:
North America: The North American market for e-prescribing is the largest in the world, driven by the widespread adoption of electronic health record (EHR) systems and the increasing focus on patient safety and efficiency in healthcare. The United States and Canada are the major contributors to the North American e-prescribing market.
Europe: Europe is the second-largest market for e-prescribing, with countries such as the United Kingdom, Germany, and France leading the adoption of e-Rx technology. The European e-prescribing market is driven by the need to improve patient safety and reduce healthcare costs.
Asia Pacific: The Asia Pacific region is expected to experience significant growth in e-prescribing adoption over the next few years, driven by increasing government initiatives to improve healthcare infrastructure and rising demand for patient safety and efficiency. Countries such as Japan, China, and India are expected to be the major contributors to the growth of the e-prescribing market in this region.
Latin America: The e-prescribing market in Latin America is still in its nascent stage, but it is expected to experience significant growth over the next few years. The market is driven by increasing government initiatives to improve healthcare infrastructure and rising demand for patient safety and efficiency. Countries such as Brazil and Mexico are expected to be the major contributors to the growth of the e-prescribing market in this region.
Overall, the e-prescribing market is growing rapidly across the globe, driven by the need to improve patient safety, reduce healthcare costs, and increase efficiency in healthcare. The North American and European markets are the largest, while the Asia Pacific and Latin American markets are expected to experience significant growth in the coming years.
Region Segment
Competitive Landscape:
The global E-Prescribing (e-Rx) market is highly competitive and fragmented with the presence of several players. These companies are constantly focusing on new product development, partnerships, collaborations, and mergers and acquisitions to maintain their market position and expand their geographical presence. Some of the key players operating in the market are:
Cerner Corporation (Oracle)
Allscripts Healthcare, LLC
Epic Systems Corporation
DrFirst
Athenahealth
NXGN Management, LLC
McKesson Corporation
Surescripts
Change Healthcare
Practice Fusion, Inc.
Networking Technology, Inc. (RXNT)
Others
Segments
By Product
Solutions
o Integrated Solutions
o Standalone Solutions
Services
o Support
o Implementation
o Training
o Network
By Delivery Mode
Web/Cloud Based
On Premise
By End-use
Hospital
Office-based Physicians
Pharmacy
By Usage Methods
Handheld
Computer Based Devices
By Substances
Controlled Substances
Non-controlled Substances
By Specialties
Oncology
Sports Medicine
Neurology
Cardiology
Others
By Geography
North America
o U.S.
o Canada
o Mexico
Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
o Rest of APAC
South America
o Brazil
o Argentina
o Colombia
o Rest of South America
MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
o Rest of MEA